Triacylglycerol utilization is required for regrowth of in vitro hypoxic nonreplicating Mycobacterium bovis bacillus Calmette-Guerin

Journal of Bacteriology

Volumn 191, Issue 16, 2009, Pages 5037-5043

  Kai, Leng Low ^a   Rao, P S Srinivasa ^d,e   Shui, Guanghou ^b   Bendt, Anne K ^b   Pethe, Kevin ^d   Dick, Thomas ^d   Wenk, Markus R ^a,b,c,e  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^d NOVARTIS INSTITUTE FOR TROPICAL DISEASES   (Singapore)

^e NONE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

1 PYRENEDECANOIC ACID; BCG VACCINE; FATTY ACID; NITRIC OXIDE; TETRAHYDROLIPSTATIN; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIOSTASIS; HYDROLYSIS; HYPOXIA; IN VITRO STUDY; LIPID METABOLISM; LIPID STORAGE; LIPID TRANSPORT; MYCOBACTERIUM BOVIS; NONHUMAN; PRIORITY JOURNAL;

BACTERIAL PROTEINS; CHROMATOGRAPHY, LIQUID; CHROMATOGRAPHY, THIN LAYER; ENZYME INHIBITORS; FATTY ACIDS; LACTONES; LIPASE; MASS SPECTROMETRY; MICROSCOPY, CONFOCAL; MYCOBACTERIUM BOVIS; OXYGEN; TRIGLYCERIDES;

BACILLI (CLASS); CORYNEBACTERINEAE; MYCOBACTERIUM BOVIS; MYCOBACTERIUM BOVIS BCG;

EID: 67749095757     PISSN: 00219193     EISSN: None     Source Type: Journal    
DOI: 10.1128/JB.00530-09     Document Type: Article

References (28)

1. Bishai, W. 2000. Lipid lunch for persistent pathogen. Nature 406:683-685.
2. Bligh, E. G., and W. J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37:911-917.
3. Bloch, H., and W. Segal. 1956. Biochemical differentiation of Mycobacterium tuberculosis grown in vivo and in vitro. J. Bacteriol. 72:132-141.
4. Boon, C., R. Li, R. Qi, and T. Dick. 2001. Proteins of Mycobacterium bovis BCG induced in the Wayne dormancy model. J. Bacteriol. 183:2672-2676.
5. Borgstrom, B. 1988. Mode of action of tetrahydrolipstatin: a derivative of the naturally occurring lipase inhibitor lipstatin. Biochim. Biophys. Acta 962:308-316.
6. Boshoff, H. I. M., and C. E. Barry. 2005. Tuberculosis-metabolism and respiration in the absence of growth. Nat. Rev. Microbiol. 3:70-80.
7. Cotes, K., R. Dhouib, I. Douchet, H. Chahinian, A. de Caro, F. Carriere, and S. Canaan. 2007. Characterization of an exported monoglyceride lipase from Mycobacterium tuberculosis possibly involved in the metabolism of host cell membrane lipids. Biochem. J. 408:417-427.
8. Daniel, J., C. Deb, V. S. Dubey, T. D. Sirakova, B. Abomoelak, H. R. Morbidoni, and P. E. Kolattukudy. 2004. Induction of a novel class of diacylglycerol acyltransferases and triacylglycerol accumulation in Mycobacterium tuberculosis as it goes into a dormancy-like state in culture. J. Bacteriol. 186:5017-5030.
9. Deb, C., J. Daniel, T. D. Sirakova, B. Abomoelak, V. S. Dubey, and P. E. Kolattukudy. 2006. A novel lipase belonging to the hormone-sensitive lipase family induced under starvation to utilize stored triacylglycerol in Mycobacterium tuberculosis. J. Biol. Chem. 281:3866-3875.
10. Garton, N. J., H. Christensen, D. E. Minnikin, R. A. Adegbola, and M. R. Barer. 2002. Intracellular lipophilic inclusions of mycobacteria in vitro and in sputum. Microbiology 148:2951-2958.
11. Garton, N. J., S. J. Waddell, A. L. Sherratt, S. M. Lee, R. J. Smith, C. Senner, J. Hinds, K. Rajakumar, R. A. Adegbola, G. S. Besra, P. D. Butcher, and M. R. Barer. 2008. Cytological and transcript analyses reveal fat and lazy persister-like bacilli in tuberculous sputum. PLoS Med. 5:e75.
12. Greenspan, P., E. P. Mayer, and S. D. Fowler. 1985. Nile red: a selective fluorescent stain for intracellular lipid droplets. J. Cell Biol. 100:965-973.
13. Hadvary, P., W. Sidler, W. Meister, W. Vetter, and H. Wolfer. 1991. The lipase inhibitor tetrahydrolipstatin binds covalently to the putative active site serine of pancreatic lipase. J. Biol. Chem. 266:2021-2027.
14. Kremer, L., C. de Chastellier, G. Dobson, K. J. C. Gibson, P. Bifani, S. Balor, J. P. Gorvel, C. Locht, D. E. Minnikin, and G. S. Besra. 2005. Identification and structural characterization of an unusual mycobacterial monomeromycolyl-diacylglycerol. Mol. Microbiol. 57:1113-1126.
15. Kridel, S. J., F. Axelrod, N. Rozenkrantz, and J. W. Smith. 2004. Orlistat is a novel inhibitor of fatty acid synthase with antitumor activity. Cancer Res. 64:2070-2075.
16. Manabe, Y. C., and W. R. Bishai. 2000. Latent Mycobacterium tuberculosis-persistence, patience, and winning by waiting. Nat. Med. 6:1327-1329.
17. Munoz-Elias, E. J., and J. D. McKinney. 2005. Mycobacterium tuberculosis isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence. Nat. Med. 11:638-644.
18. Parker, S. K., R. M. Barkley, J. G. Rino, and M. L. Vasil. 2009. Mycobacterium tuberculosis Rv3802c encodes a phospholipase/thioesterase and is inhibited by the antimycobacterial agent tetrahydrolipstatin. PLoS ONE 4:e4281.
19. Reed, M. B., S. Gagneux, K. DeRiemer, P. M. Small, and C. E. I. Barry. 2007. The W/Beijing lineage of Mycobacterium tuberculosis overproduces triglycerides and is constitutively upregulated for the DosR dormancy regulon. J. Bacteriol. 189:2583-2589.
20. Russell, D. G. 2003. Phagosomes, fatty acids and tuberculosis. Nat. Cell Biol. 5:776-778.
21. Segal, W., and H. Bloch. 1957. Pathogenic and immunogenic differentiation of Mycobacterium tuberculosis grown in vitro and in vivo. Am. Rev. Tuberc. 75:495-500.
22. Sirakova, T. D., V. S. Dubey, C. Deb, J. Daniel, T. A. Korotkova, B. Abomoelak, and P. E. Kolattukudy. 2006. Identification of a diacylglycerol acyltransferase gene involved in accumulation of triacylglycerol in Mycobacterium tuberculosis under stress. Microbiology 152:2717-2725.
23. Stover, C. K., P. Warrener, D. R. VanDevanter, D. R. Sherman, T. M. Arain, M. H. Langhorne, S. W. Anderson, J. A. Towell, Y. Yuan, D. N. McMurray, B. N. Kreiswirth, C. E. Barry, and W. R. Baker. 2000. A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis. Nature 405:962-966.
24. Takayama, K., H. K. Schnoes, E. L. Armstrong, and R. W. Boyle. 1975. Site of inhibitory action of isoniazid in the synthesis of mycolic acids in Mycobacterium tuberculosis. J. Lipid Res. 16:308-317.
25. Waddell, S. J., R. A. Stabler, K. Laing, L. Kremer, R. C. Reynolds, and G. S. Besra. 2004. The use of microarray analysis to determine the gene expression profiles of Mycobacterium tuberculosis in response to anti-bacterial compounds. Tuberculosis 84:263-274.
26. Wayne, L. G., and L. G. Hayes. 1996. An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence. Infect. Immun. 64:2062-2069.
27. Wayne, L. G., and C. D. Sohaskey. 2001. Nonreplicating persistence of Mycobacterium tuberculosis. Annu. Rev. Microbiol. 55:139-163.
28. Zhang, Y. 2005. The magic bullets and tuberculosis drug targets. Annu. Rev. Pharmacol. Toxicol. 45:529-564.